Table 1:
Condition | No. of studies | No. of case definitions/validations | Sensitivity (range) | Specificity (range) | PPV (range) | NPV (range) |
---|---|---|---|---|---|---|
IIH | 3 | 4 | 54–91% | 74–85% | ||
GCA | 2 | 2 | 30–96% | 94% | ||
Optic neuritis | 3 | 6 | 76–99% | 83–100% | 25–100% | 98–100% |
NMO | 1 | 3 | 60% | 100% | 43–100% | 100% |
Cranial nerve palsy | 1 | 3 | 98–99% | |||
MG | 2 | 6 | 53–97% | 99–100% | 5–90% | 100% |
NAION | 0 | |||||
TED | 0 | |||||
Blepharospasm | 0 |